Batm Advanced Communicat... Share Discussion Threads

[doccash] 30/7/2020 06:59

On July 26, the Israeli Defense, Foreign Affairs and Health ministries sent a delegation to India, led by the Defense Ministry’s Directorate of Defense Research and Development (DDR&D), to determine the effectiveness of four promising rapid diagnostic solutions.

As a thank-you gift to their hosts, the delegation of about 20 individuals brought equipment, including ventilators, donated by the Ministry of Foreign Affairs and members of the private sector to assist India in dealing with the pandemic.

I wonder who supplied the ventilators? Good pr to open door to enormous Indian market

[doccash] 30/7/2020 06:55

hxxps://www.israel21c.org/israeli-rapid-covid-19-lab-diagnostic-kits-in-production/

Obviously we are pretty overwhelmed [with requests] but I believe in a few weeks we will be able to ship our kit to almost everybody that wants it,” Marom said today (March 19).

[icemaninvestor] 30/7/2020 00:12

BATM are featured in this article which confirms the home test kits are being released around September.

[rawdeal1] 29/7/2020 21:35

Also .......... People going for surgery are being tested routinely (ie. even if they don't have symptoms) - just think - how many ops get done in 1 yr.

[doccash] 29/7/2020 21:29

Hi iceman nail on head Everyone has spikes post release covid lockdown. If you watch BBC you think it's just UK problem. Everyone is experiencing the same issue if you release lockdown it comes back see Hong Kong as an example. The only way to react is some form of testing whether clinically it actually is definite science. There will need to be a compromise to reduce risk and that will involve extensive testing. The main concern is winter with differentiating covid flu etc.If we have a solution that is immense game changer

[icemaninvestor] 29/7/2020 20:16

I said it in March & I’ll say it again now. The game-changer for BATM is the covid sputum tests (think pregnancy type test) which give results in minutes. The tests are due for release in September. If these are the same gold standard as the rest of the covid 19 tests then they will sell in the multi-millions. The only constraint is the manufacturing capacity which Zvi stated was 250,000 kits per month. However, Zvi added that they would be looking for help with manufacturing to increase this number.

[fse] 29/7/2020 16:27

Heres my current take FWIW
Its inappropriate for either myself Tom or anyone else to make judgemental BUY or SELL for anyone else other than ourselves. No problem with Toms post as I think thats what he is saying and did not take it as trying to drive down the share price for whatever reason.
This is a long term core holding for me but I do keep a % of trading shares to deal with the peaks and troughs.
I let this run and when we saw a downturn sold my trading batch @135p, these I only had for a short period from 82p.

I would FMV BATM at the moment at @ 85p on sales and fundamentals.
The issue here is that they are sitting on valuable IP. The medical division infectious diseases is a comparatively new market for the approach they are taking. The Telco sector is providing essential architecture for 5G solutions especially if it finds it way into all ARM processors via NVFTime. Watch this space.

So expected trading range IMO. 85p - 125p range .... thats a big range I know but short term thats my best guess. They were significantly undervalued prior to the rise.
Problem here is that its risky being out of them as there are multiple fronts they could announce on at any time and these prices are going to look cheap.

[rawdeal1] 29/7/2020 16:22

Bouncing back ... someone is gobbling up the sells ... :)

[74tom] 29/7/2020 15:57

Glad to see I'm not the only one struggling to back up the increase in value here, the only hard data provided was the sales value for the ventilators & the projected revenue increase YoY vs 2019 (25% minimum), you can't objectively say that those pieces of information can back up a 200% share price rise. Time to consolidate I think...

[car1pet] 29/7/2020 15:51

Markyt not sure what you mean by "they got enough back now". Its a market made of buyers and sellers. The price is a result of the market activity. The stock needs to find a support level then you can assess what to do. At the moment IMO its difficult to say where the support level sits. 80p is a total guess but given the positive statements from the company it could be a fair price. We will have to wait and see. All IMO DYOR

[doccash] 29/7/2020 15:43

125 was 50/% retrace from climb from £1 to £1.50 so may bounce back from here

[markyt] 29/7/2020 15:33

Do you think they got enough back now for a big buy to move in for a slice ?

[car1pet] 29/7/2020 15:22

Quite high volume today over 2m trades. Its difficult to value at the moment. IMO its a wait and see it could go either way. It was very rapid rise to 150 based on not a lot of hard data. As someone else said 80p could be a fair price. 6 months ago 65p looked ambitious.

[doccash] 29/7/2020 14:46

BATM's Zvi Marom expects 'substantial revenue' from its three new diagnostic kits

Substantial is what he said
Bear in mind long term holders have been excited by the telecom potential in the company and covid has been a large cherry on top for testing,but will also eventually increase demand for 5g networks and security through increase home working Hence BATM will make more progress

[paulisi] 29/7/2020 14:25

Very interesting discussion and quite a surprising demand drop.If you look at the covid related shares they all jumped on speculation and were overvalued.I think in some ways you can say that about BATM. However they have revenue streams across multiple areas.In terms of the ventilators. This is a first border, so no history of revenues and it was produced in Hungary for the Hungarian government.The issue BATM had with covid tests is that they needed to sell the equipment with the test.Agricultural waste treatment is becoming more high profile especially in India and may open due markets.On the Telco side, there has been big demand for product with more people working from home and companies having to upgrade. Also opportunities within 5G market with Huaweii issues.The market is looking ahead at potential rather than actual and it has surprised me on how much the valuation has increased.I guess we will have further information shortly when the interim come out.The new tests work on any PCR and thus open up new markets(UK, India, US) and the home tests could be a game changer.

[doccash] 29/7/2020 13:41

So you know the margin on the ventilator contracts, don't see covid testing as a major income generator and wisely say 70 80 p price According to your first piece wildly overpriced before covid Just say you are shorting and good luck

[cumnor] 29/7/2020 13:39

Tom, You also ignore the Telco side of things, concentrating solely on Covd requirements but the recent announcement about expanding their medical division and, in particular, their other anti infective or waste disposal platforms which, given the world has just woken up to what infections can do, is helping drive sentiment. BATM has been around a long time but parts of its portfolio have potential for rapid growth in sales and profits. Were this a Nasdaq company it would be valued entirely differently, and not just on historical metrics.

[74tom] 29/7/2020 13:32

@Cumnor, what part of my post was gibberish? The part that you didn't agree with? Yes they are in a strong position, but a 25% revenue increase vs a 200% share price increase, from an already expensive starting point, doesn't add up. I did some research this morning and considered buying in at £1.33, but couldn't justify it based on the valuation, I'll watch it but until they report their results there is too much risk buying at this level.

And I imagine that the margin on the ventilator contract would be tight, say 10-20%, as it would have been a very competitive tender process...

[markyt] 29/7/2020 13:13

Tree shake

[volsung] 29/7/2020 13:07

I’m buying this dip

[doccash] 29/7/2020 13:01

I would also check the child like glie in zvi' eyes when discussing revenues in proactive investor interview. Could not elaborate as in closed period before results

[doccash] 29/7/2020 12:59

30 million ventilator contract bet the profit margin was good

[cumnor] 29/7/2020 11:55

If you spend as long doing a bit of research into what BVC does first tom -it has a wide portfolio of businesses and covid is a bonus but their wide anti infective testing platforms and equipment have huge potential long term also for future epidemics-as you do into writing gibberish then you might get an idea of why BVC is going.

[74tom] 29/7/2020 11:47

This appears very overvalued when you consider the market cap increase since the start of Covid vs the incremental revenue increase reported in the recent trading update.

Pre covid announcements, this traded at 45p or so, a market cap of £190m with 440m shares in issue. Profit before tax for 2019 was $4.7m, so this was already on a heady P/E of 50 ish. However, you could certainly argue they were fairly valued, given the strong order book, diversified business model & strong second half of 2019.

Taking today's share price of £1.31, they have added a remarkable £378m to their market cap since the start of Covid. The recent trading update included the following commentary;

"As a result of the considerable growth in the Bio-Medical division, which has more than offset any loss of revenues in the Networking & Cyber division, BATM now expects to report a substantial increase in FY 2020 revenues, at least 25% higher than FY 2019 and materially higher than market expectations. It also expects to report EBITDA significantly ahead of market expectations"


We know 2019 revenues were $123m, so a 25% increase would get to $153m for 2020, this goes nowhere near justifiying a £378m incremental increase in market cap?

Compare this to a competitor in the Covid sphere such as NCYT, who have reported £72m revenue for H1 2020, and the increase here starts to look rather bizarre. How much incremental revenue will they actually generate from Covid sales? It will need to be a hell of a lot to back up the current market cap of £575m. Take profits IMO - a correction back to 70-80p would be entirely unsurprising.

[steeplejack] 29/7/2020 08:36

Indeed but the suggested cost to passengers would be £150.I don't see family holiday makers readily paying that much.The erratic and inconsistent government approach will start to irritate the general public.One minute the government tell everyone they'll have to isolate if they return from Spain.Next minute they're told they can avoid lockdown if they have a £150 test.An expense for a family that could actually dwarf the cost of cut price flights.